Rapid growth, dynamic and effective product line, thriving as a small cap company in a difficult environment

April 13, 2017
00:0000:00

 

ToddDavis_Endexx.png

 

Todd Davis, the CEO & Founder of Endexx Corporation, a diversified company with two key operating entities (M3Hub/Autospense Technologies & CBD Unlimited-Hemp Nutraceuticals joins eHealth Radio and the Diabetes, Health News & Nutrition & Pain Management Channels. Todd has 26 years experience in the Investment Banking and Small Cap Markets.

 

Listen to interview with host Eric Michaels and guest Todd Davis discuss the following:

  • Why are phytocannabinoids so important for quality wellness?
  • What methods and testing are you using with CBD?
  • How are your products helping People and Pets?
  • How well are your products performing in the market?
  • On the side, how are your developments with Autospense Progressing?
  • Are you uplisting and completing your Audit?

 

Todd Davis is Chairman and CEO of Endexx Corporation and has been since 2003. Todd was an Investment Banker/Stockbroker, and trading analyst from1990-2000. He also serves and has served as CEO/President/CFO/COB and Director in multiple publicly traded companies from 2001-2016 (present).

Endexx provides innovative inventory management and technology solutions. Endexx, with its collaborative partners and consultants, develops and distributes two consumable product lines derived from industrial hemp, which is organic and naturally rich in phytocannabinoids. Phyto-Bites®, is its CBD-infused soft chews for dogs. The dog treats are formulated to promote health and support the reduction of separation anxiety, pain and inflammation. The company also has two technology products and services that launched in 2014 -- the M3hub and the Autospense™. Both products provide essential solutions to promote regulatory compliance and full

Endexx accountability through "seed to sale" inventory management and an "End of Sale" technology integration. Based on principles developed by the pharmacological industry, the m3hub platform is the first standardized software solution for tracking pharmaceutical grade marijuana that maintains compliance with federal, state and local regulations. It is intended to provide a smooth transition to eventual federal mandates. The Autospense™ is a commercial grade inventory control and dispensing device that provides up-to-the-minute accounting details and ensures both product and patient security. By automating the dispensing process, Autospense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers.

 

Screen_Shot_2016-11-01_at_6_16_31_PM.png

 

Websiteswww.endexx.com | www.cbdunlimited.com

21 Things You Need to Know About Diabetes & Weight Loss Surgery

March 3, 2017
00:0000:00

Screen_Shot_2017-03-03_at_10_53_01_AM.png

 

Dr. Scott Cunneen, Director of Metabolic and Bariatric Surgery at Cedars-Sinai Medical Center in Los Angeles, and author of a new book just published by the American Diabetes Association called 21 Things You Need to Know About Diabetes & Weight Loss Surgery again joins eHealth Radio and the Diabetes & Weight Management Channels.

 

Listen to interview with host Eric Michaels and guest Dr. Scott Cunneen discuss the following:

  • We talked with you a few years ago when your first book on weight loss surgery was published.  What’s different in this new book?
  • So does weight loss surgery actually provide a cure for diabetes?
  • With more than 200,000 weight loss surgical procedures performed every year in this country, wouldn’t you think the number of people with diabetes would be going down instead of up?
  • Which weight loss procedures work the best on diabetes?
  • How would you suggest people start finding out if weight loss surgery is right for them, whether or not they have diabetes?

 

Scott A. Cunneen, MD, FACS, FASMBS, is Director of Metabolic and Bariatric Surgery at Cedars-Sinai Medical Center in Los Angeles.  A graduate of the University of Notre Dame, he hold a master's degree in physiology from Georgetown University and a master's degree in human nutrition from the Columbia University College of Physicians and Surgeons. He earned his medical degree from Georgetown University. 

 

21_Things_-_final_cover_2_.jpg

 

A Fellow of the American Society of Metabolic & Bariatric Surgeons, Dr. Cunneen also serves on the editorial advisory board of DiabeticLifestyle.com and EndocrineWeb.com, and is often called upon to teach laparoscopic procedures throughout the U.S. and abroad. He is the author of 21 Things You Need to Know About Diabetes & Weight Loss Surgery, published by the American Diabetes Association.

Sugar’s impact on our health with Keren Slutzkin

January 4, 2017
00:0000:00

Keren_Profile_Smaller.png

 

Keren Slutzkin, Founder of Vital Assurance joins eHealth Radio and the Nutrition & Health News Channels. Keren is a certified Health and Wellness coach, article writer, recipe developer and cooking demonstrator who specialises in inspiring other mums to live healthier, happier lives.

 

Listen to interview with host Eric Michaels & guest Keren Slutzkin discuss the following:

  • Keren, can you please tell us a little about yourself and your own health journey?
  • What are the positive implications you have seen within yourself and your family after making these changes?
  • It is becoming apparent that there is a health epidemic in relation to obesity and diabetes.  What is your understanding of what could be contributing to this?
  • What is your biggest concern in regards to the world's current sugar consumption?
  • What are some signs that someone may be a sugar addict?
  • If you are telling people to reduce the amount of carbohydrates that they are consuming, then what food options are left for them to eat?
  • What are some tips that you could provide our listeners with if they were considering to reduce their sugar consumption.

 

Keren Slutzkin is a mum of 2 young boys and the founder of Vital Assurance.  She is a holistic Health and Wellness coach, health article writer, recipe developer and cooking demonstrator that specialises in inspiring other mums and their families to live healthier, happier lives.  
 
Her passion is coaching mums that are overwhelmed with conflicting information around health, that don't enjoy being in the kitchen cooking, and need some additional guidance in making better decisions around their health and food choices. She is really passionate about food, and enjoy creating and sharing nutritious, budget friendly meals for everyone to enjoy. 

 

VA_Logo_Smaller.png

Website: http://vitalassurance.com.au

 

Social Media Links:
Facebook: http://facebook.com/vitalassurance
Instagram: http://instagram.com/vitalassurance

For a complimentary 30 minute consultation, contact Keren at info@vitalassurance.com.au.

New Pre-Meal Drink Offering Hope for those with Type 2 Diabetes

November 20, 2016
00:0000:00

 

Arie_Nudel_Omniblend_Innovation_3_1_.jpg

Arie Nudel, the Managing Director of Omni Innovation, which specialises in medical nutrition joins eHealth Radio and the Diabetes and Health News Channels.

Omni Innovation makes a unique pre-meal drink for people with Type 2 diabetes that reduces the Glyceamic Index (GI) of your food and drink and controls the spikes in blood glucose which, over time, can cause serious damage.

Listen to interview with host Eric Michaels and guest Arie Nudel discuss the following:

  • What is Omni Innovation and GlucoControl?
  • Why did you decide to try and make a product for those with type 2 diabetes?
  • What can GlucoControl do to help those with Type 2 diabetes?
  • Why hasn’t something like this been developed before?
  • What is the scope for wider distribution of this product? Does it have global appeal?

Duration: 11:14

Omniblend Innovation creates unique and specialised food grade products that can be used by people with diabetes and other health conditions. Clinical validation of our products is supervised by our expert collaborator network to ensure that our customers have safe, effective and clinically tested products.

Our flagship product, GlucoControl, is a patented pre-meal drink that smooths out the blood glucose spike after a meal for people with type 2 diabetes and pre-diabetes.

Type 2 diabetes is one of Australia’s most prevalent and fast growing chronic diseases. More than 200 Australian’s develop the condition every day.

Over 1 million Australians currently have type 2 diabetes and an additional 1.5 million have pre-diabetes. Globally over 380 million people have type 2 diabetes – this does not count people with pre-diabetes. China alone has more than 200 million people with diabetes or pre-diabetes.

Clinical testing and validation of GlucoControl was conducted at The Baker IDI Heart and Diabetes Institute in Melbourne, Australia www.bakeridi.edu.au under the supervision of Professor Peter Clifton. Peter is the co-author of the successful CSIRO Total Health and Well-being Diet.

Arie-logo-full.jpg

Website: www.omniblendinnovation.com.au

Phyto Nutrients for Health: The next big Oil Boom.

November 1, 2016
00:0000:00


Todd Davis, the CEO & Founder of Endexx Corporation, a diversified company with two key operating entities (M3Hub/Autospense Technologies & CBD Unlimited-Hemp Nutraceuticals joins eHealth Radio and the Health News & Nutrition Channels. Todd has 26 years experience in the Investment Banking and Small Cap Markets.


Listen to interview with host Eric Michaels and guest Todd Davis discuss the following:

  • What's your background and how did you get into the CBD Industry?
  • What research or testing have you done with your products?
  • How do the products help people, how do they help pets?
  • What kind of feedback do you get from your customers?


Todd Davis is Chairman and CEO of Endexx Corporation and has been since 2003. Todd was an Investment Banker/Stockbroker, and trading analyst from1990-2000. He also serves and has served as CEO/President/CFO/COB and Director in multiple publicly traded companies from 2001-2016 (present).



Websiteswww.endexx.com | www.cbdunlimited.com | www.m3hub.com

The 9 Carbs to Avoid for a Healthy Life

March 25, 2016
00:0000:00


Dr. Bruce Roseman the author of book "The Addictocarb Diet:  Avoid the 9 Highly Addictive Carbs while Eating Anything Else You Want" joins eHealth Radio and the Diabetes, and Health News Channels. Dr. Roseman is a family doctor in practice in Manhattan for over 30 years affiliated with Mount Sinai Hospital.


Listen to interview with host Eric Michaels and guest Dr. Bruce Roseman discuss the following:

  • Why are certain carbs so dangerous?

  • Why did you write “The Addictocarb Diet?”

  • What are the steps to take to eliminate a carb addiction?
  • It seems simple, but why can’t people shake the addiction?
  • Why does your diet, as opposed to Weight Watchers, work?
  • Does your diet prohibit chocolate?

  • What foods do you recommend that listeners eliminate as everyone thinks about weight loss and resolutions to live healthier?


Duration: 32:26


Dr. Bruce Roseman has been a Family Doctor in private practice in Manhattan for 30 years, and is affiliated with Mount Sinai Hospital where he holds joint appointments in the departments of Family Medicine and Ob/Gyn.


He has served as medical editor for several food/health-related books and magazines including The Olive Oil Cookbook, The Low Cholesterol Oat Cure, Whittle’s The Health Report, Big Bird Goes to the Doctor (Sesame Street), and as a medical columnist for Woman’s World.


Dr. Roseman has appeared on numerous television and radio programs as a medical expert, including Live Wire (PBS), The Human Condition (NPR) Good Day New York, The Queen Latifah Show, and The Joan Lunden Show, and has been featured in magazines such as Guideposts and Parent.


He is also the author of A Kid Just Like Me (Penguin/Putnam, 2001), which details a popular method he invented to teach children with learning disabilities to read, while working with his son.


Dr. Roseman lives happily, in New York City, with his wife of over a quarter century, Ellen, and is proud to be the father of two fine young men, Joshua and Aaron.



Website: www.addictocarb.com
Facebook: https://www.facebook.com/addictocarb

Managing Diabetes in the Digital World – Introducing the DARIO

September 9, 2015
00:0000:00


Todd Durniak, Executive VP of US Operations at  Labstyle Innovations that powers the DARIO, a unique diabetes management platform that allows patients and doctors seamlessly manage their condition joins eHealth Radio and the Diabetes, Health News & Technology Channels.

Listen to interview with host Eric Michaels and guest Todd Durniak discuss the following:

  • For those living with diabetes, what would you say is the major challenge in managing this condition today?
  • How can your platform technology, Dario™ Diabetes Management Solution address this challenge? Can you explain how it works with smart devices such as phones and ipads? 
  • There’s a lot of technology out there to help People with Diabetes manage their disease.  How is DARIO different?
  • Aside from the DARIO user, who else can access remotely the blood sugar meter readings? Why is this information important?  
  • Labstyle Innovations has an online Facebook community called the DARIO Lounge. Why are these community groups so important in helping patients stay compliant and healthy? 
  • The DARIO platform also includes a suite of apps for the smartphone -- How do they work in the overall success for diabetic patients? Would the apps be available for non-diabetic patients?
  • Can you share where the DARIO is currently available and when will be available for US patients?


Duration: 9:26



Todd Durniak is Labstyle Innovations’s Senior Vice President and General Manager for the U.S.  Durniak brings to LabStyle over 20 years of medical device commercial and technical leadership, most recently as the Vice President and General Manager of Neighborhood Diabetes, a division of Insulet focused on delivering insulin supplies through durable medical equipment (DME) and pharmacy channels with a 'high touch' training approach. 


Prior to Insulet and Neighborhood Diabetes, Durniak held a number of positions of increasing responsibility over 7 years at Smith & Nephew Orthopedics, most recently as President, Asia Pacific, based in Sydney, Australia. 


Durniak began his career in engineering with Johnson & Johnson Orthopedics, leaving to start and manage Texas Direct Medical, an orthopedic product distributorship.  He later re-joined Johnson & Johnson post the acquisition of DePuy, moving through a series of positions before joining Guidant just prior to its acquisition by Boston Scientific.


Durniak holds a BS of Engineering in Biomedical Engineering from the University of Vermont and an MBA from Boston University.



Website: www.MyDario.com

Oral Insulin and Diabetes: How Close are we to this Medical Breakthrough?

August 5, 2015
00:0000:00


Josh Hexter, Chief Operating Officer of Oramed Pharmaceuticals, a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems including what would be the first oral formulation of insulin joins eHealth Radio and the Diabetes, Pharmaceutical, & Health News Channels.


Listen to interview with host Eric Michaels and guest Josh Hexter discuss the following:

  • Many listeners may be familiar with diabetes, either they are affected or know a family member affected by the condition. Can you explain to our listeners the differences between the Type I and II diabetes? What toll does this disease create?
  • What role does insulin play in diabetes? 
  • Why has it taken so long for researchers to turn insulin into a pill? What has been the challenges? 
  • Your company is working on an oral version of insulin. Can you describe how does it work and what stage are you in drug’s development? 
  • Can you explain why treating patients who may be at risk for Type II diabetes (prediabetes) with Oramed’s oral pill? What protection does the oral version of insulin provide?


Duration: 14:35


Mr. Hexter serves as Chief Operating Officer and Vice President of Business Development of Oramed Pharmaceuticals, which he joined in 2013. He brings to Oramed more than 15 years of prominent leadership, business development, operations know-how and management in the life science sector. He was most recently Executive Director of Corporate In-Licensing at BioLineRx Prior to joining BioLineRx, he worked in private equity and venture capital where he served as CEO of a VC-backed startup.


As CEO of Biosensor Systems Design, Mr. Hexter was instrumental in shaping the company’s strategic focus and in forging business development agreements with Fortune 100 companies in the areas of food safety, medical diagnostics and homeland security. Mr. Hexter earned a bachelor’s degree from the University of Wisconsin and a master’s degree in management from Boston University.



Website: www.oramed.com

Glucose Health Assists Type 2 Diabetes Patients in New Product Category

June 30, 2015
00:0000:00


Kelly Coughlin, the Corporate Spokeswoman and PR Advisor to Glucose Health, Inc. that helps keep your blood sugar balanced joins eHealth Radio and the Diabetes, Health News & Supplement Channels.


Listen to interview with host Eric Michaels & guest Kelly Coughlin discuss the following:

  • What is Glucose Health and why is it an important component of combating Type 2 diabetes?
  • What are the active ingredients in the product?
  • Who developed the formula for Glucose Health?
  • Why is this product different from others on the market?
  • Type 2 diabetes is becoming an epidemic in the U.S.; can Glucose Health help lower the number of affected Americans?
  • Share with us if you would success stories of people using this product.
  • When will Glucose Health be available to consumers in mass market?
  • Where can consumers purchase the product now?


Duration: 9:55


The Centers for Disease Control and Prevention estimates two in five Americans will develop Type 2 diabetes in their lifetime. Addressing the key lifestyle factors that lead to Type 2 diabetes today, will keep you healthy in the future!  Make Glucose Health® a part of your commitment to healthy living.  Certain clinical studies indicate the 6 key natural ingredients in the Glucose Health® formula have important relationships to glucose, insulin, triglycerides and HDL ("good" cholesterol).


Kelly Coughlin is President of Annex Communication. For a decade and a half, Kelly Coughlin has worked as a publicist and strategist between the CPG/retail, healthcare, real estate, media, and sports & entertainment industries.


Her experience includes: building national advertising and public relations platforms, negotiation and creation of national media and sports/entertainment sponsorships, creation of Interactive platforms supported by SEO/SEM practices, and high-profile individual management. Ms. Coughlin has represented entertainers, athletes, physicians, Fortune 500 executives, national brands, sports organizations, festivals and tours, real estate companies and retailers.

Ms. Coughlin holds a B.A. in Communication from Boston College.




Website
: www.glucosehealth.com

New Advances in Diabetes Treatment: Insulin-Producing Cells That Could Replace Injections

May 20, 2015
00:0000:00


Dr. Gerald Crabtree, Chief Operating Officer and Director at PharmaCyte Biotechnology, a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box joins eHealth Radio and the Diabetes and Health News Channels.


Listen to interview with host Eric Michaels and guest Dr. Gerald Crabtree discuss the following:

  • In an effort to understand how the Melligen cells works, can you explain what happens to the pancreas in Type 1 diabetes?
  • Why are liver cells such good candidates to replace the damaged cells in the pancreas?
  • What have early lab trials shown?
  • How does PharmaCyte’s Cell-in-the-Box help the melligen cells do their jobs?
  • How will this technology help the lives of those patients living with Type 1 Diabetes?


Duration: 15:55


Dr. Gerald Crabtree is PharmaCyte’s Chief Operating Officer. Since 1985, Dr. Crabtree has been involved with various biopharmaceutical companies where he has alternatively supervised and coordinated the development of multiple drug candidates, prepared clinical protocols, investigator brochures, monographs, and research and review articles and served as project manager for development of major oncologic agents. He is a Member of the American Society of Clinical Oncology and also is a past member of research grant review committees for the National Institute of Health and the American Cancer Society. Dr. Crabtree established and directed, from inception, a department that monitored and coordinated the development of oncologic and immunologic drugs from initial discovery through regulatory approval in a major pharmaceutical company and served as project manager for the development of the anticancer agent, Taxol®.


Dr. Crabtree received his Ph.D. in Biochemistry from the University of Alberta, Edmonton, Alberta, Canada and has published over 80 articles in peer-reviewed journals. He is a National Cancer Institute of Canada Research Fellow. In addition, he served as Department Head of Molecular Pharmacology for the Nucleic Acid Research Institute, and prior to that as Associate Professor of Medicine with the Roger Williams Cancer Center at Brown University. Dr. Crabtree has also served as Director of Project Planning and Management (Oncology/Immunology) at Bristol-Myers Squibb and as Vice-President of Research and Development at ETEX Corporation.



Website: www.pharmacytebiotech.com